| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |